Institutional investors purchased a net $6.1 million shares of NVO during the quarter ended September 2016, and now own 9.23% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
G. W. HENSSLER & ASSOCIATES LTD. Bought 104.5 Thousand shares of Novo Nordisk
CIBC WORLD MARKETS, INC. Bought 74.0 Thousand shares of Novo Nordisk
SARATOGA RESEARCH & INVESTMENT M... Bought 70.1 Thousand shares of Novo Nordisk